Pharmacogenomics in diabetes mellitus: insights into drug action and drug discovery
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacogenomics in diabetes mellitus: insights into drug action and drug discovery
Authors
Keywords
-
Journal
Nature Reviews Endocrinology
Volume 12, Issue 6, Pages 337-346
Publisher
Springer Nature
Online
2016-04-11
DOI
10.1038/nrendo.2016.51
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin and the gastrointestinal tract
- (2016) Laura J. McCreight et al. DIABETOLOGIA
- Safety of antidiabetes medications: An update
- (2015) CJ Bailey CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Current Drug Treatment Landscape for Diabetes and Perspectives for the Future
- (2015) CJ Bailey CLINICAL PHARMACOLOGY & THERAPEUTICS
- Weight Management in Type 2 Diabetes: Current and Emerging Approaches to Treatment
- (2015) Luc Van Gaal et al. DIABETES CARE
- Recessive mutations in the cancer gene Ataxia Telangiectasia Mutated (ATM ), at a locus previously associated with metformin response, cause dysglycaemia and insulin resistance
- (2015) P. J. Connelly et al. DIABETIC MEDICINE
- Organic cation transporter 1 variants and gastrointestinal side effects of metformin in patients with Type 2 diabetes
- (2015) T. Dujic et al. DIABETIC MEDICINE
- Recent advances in understanding the genetic architecture of type 2 diabetes
- (2015) Karen L. Mohlke et al. HUMAN MOLECULAR GENETICS
- UK gears up to decode 100 000 genomes from NHS patients
- (2015) Nayanah Siva LANCET
- Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota
- (2015) Kristoffer Forslund et al. NATURE
- The support of human genetic evidence for approved drug indications
- (2015) Matthew R Nelson et al. NATURE GENETICS
- Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci
- (2015) Kyle J Gaulton et al. NATURE GENETICS
- Genetic variance estimation with imputed variants finds negligible missing heritability for human height and body mass index
- (2015) Jian Yang et al. NATURE GENETICS
- Understanding multicellular function and disease with human tissue-specific networks
- (2015) Casey S Greene et al. NATURE GENETICS
- A New Initiative on Precision Medicine
- (2015) Francis S. Collins et al. NEW ENGLAND JOURNAL OF MEDICINE
- GWAS and drug targets
- (2014) Chen Cao et al. BMC GENOMICS
- Pathways Targeted by Antidiabetes Drugs Are Enriched for Multiple Genes Associated With Type 2 Diabetes Risk
- (2014) Ayellet V. Segrè et al. DIABETES
- Association of Organic Cation Transporter 1 With Intolerance to Metformin in Type 2 Diabetes: A GoDARTS Study
- (2014) Tanja Dujic et al. DIABETES
- High heritability and genetic correlation of intravenous glucose- and tolbutamide-induced insulin secretion among non-diabetic family members of type 2 diabetic patients
- (2014) Anette P. Gjesing et al. DIABETOLOGIA
- Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: rationale and design of the epidemiological studies within the IMI DIRECT Consortium
- (2014) Robert W. Koivula et al. DIABETOLOGIA
- RS11212617 is associated with metformin treatment response in type 2 diabetes in Shanghai local Chinese population
- (2014) Y. Zhou et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Clinical development success rates for investigational drugs
- (2014) Michael Hay et al. NATURE BIOTECHNOLOGY
- Zinc transport and diabetes risk
- (2014) Ewan Pearson NATURE GENETICS
- Identification of low-frequency and rare sequence variants associated with elevated or reduced risk of type 2 diabetes
- (2014) Valgerdur Steinthorsdottir et al. NATURE GENETICS
- Loss-of-function mutations in SLC30A8 protect against type 2 diabetes
- (2014) Jason Flannick et al. NATURE GENETICS
- Drug makers and NIH team up to find and validate targets
- (2014) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Personalized pharmacogenomics profiling using whole-genome sequencing
- (2014) Clint Mizzi et al. PHARMACOGENOMICS
- An update on the pharmacogenomics of metformin: progress, problems and potential
- (2014) Jennifer N Todd et al. PHARMACOGENOMICS
- Statistical Power to Detect Genetic (Co)Variance of Complex Traits Using SNP Data in Unrelated Samples
- (2014) Peter M. Visscher et al. PLoS Genetics
- Heritability of variation in glycaemic response to metformin: a genome-wide complex trait analysis
- (2014) Kaixin Zhou et al. Lancet Diabetes & Endocrinology
- Genotype to phenotype via network analysis
- (2013) Hannah Carter et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- The CTRB1/2 Locus Affects Diabetes Susceptibility and Treatment via the Incretin Pathway
- (2013) Leen M. ‘t Hart et al. DIABETES
- Clinical and Genetic Determinants of Progression of Type 2 Diabetes: A DIRECT Study
- (2013) Kaixin Zhou et al. DIABETES CARE
- Dapagliflozin treatment for type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials
- (2013) Mei Zhang et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- The diabetes-susceptible gene SLC30A8/ZnT8 regulates hepatic insulin clearance
- (2013) Motoyuki Tamaki et al. JOURNAL OF CLINICAL INVESTIGATION
- Emerging LDL therapies: Using human genetics to discover new therapeutic targets for plasma lipids
- (2013) Jonathan C. Cohen Journal of Clinical Lipidology
- Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP
- (2013) Russell A. Miller et al. NATURE
- Discovery and refinement of loci associated with lipid levels
- (2013) Cristen J Willer et al. NATURE GENETICS
- Validating therapeutic targets through human genetics
- (2013) Robert M. Plenge et al. NATURE REVIEWS DRUG DISCOVERY
- Sequencing studies in human genetics: design and interpretation
- (2013) David B. Goldstein et al. NATURE REVIEWS GENETICS
- Structure and dynamics of molecular networks: A novel paradigm of drug discovery
- (2013) Peter Csermely et al. PHARMACOLOGY & THERAPEUTICS
- Association betweenTCF7L2Genotype and Glycemic Control in Diabetic Patients Treated with Gliclazide
- (2013) Martin Javorský et al. International Journal of Endocrinology
- Pharmacogenetics of Oral Antidiabetic Drugs
- (2013) Matthijs L. Becker et al. International Journal of Endocrinology
- Pharmacogenomics of adverse drug reactions
- (2013) Ann K Daly Genome Medicine
- SGLT inhibitors in management of diabetes
- (2013) Abd A Tahrani et al. Lancet Diabetes & Endocrinology
- PPAR-γ2 and PTPRD gene polymorphisms influence type 2 diabetes patients' response to pioglitazone in China
- (2012) Qi Pei et al. ACTA PHARMACOLOGICA SINICA
- Five Years of GWAS Discovery
- (2012) Peter M. Visscher et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Insights from Genome-Wide Association Studies of Drug Response
- (2012) Kaixin Zhou et al. Annual Review of Pharmacology and Toxicology
- Network Medicine Strikes a Blow against Breast Cancer
- (2012) Janine T. Erler et al. CELL
- A Systems Genetics Approach Identifies Genes and Pathways for Type 2 Diabetes in Human Islets
- (2012) Jalal Taneera et al. Cell Metabolism
- A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: a replication and meta-analysis of five cohorts
- (2012) N. van Leeuwen et al. DIABETOLOGIA
- Differential network biology
- (2012) Trey Ideker et al. Molecular Systems Biology
- Pharmacogenomics in clinical practice and drug development
- (2012) Andrew R Harper et al. NATURE BIOTECHNOLOGY
- Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes
- (2012) NATURE GENETICS
- Effect of a Monoclonal Antibody to PCSK9 on LDL Cholesterol
- (2012) Evan A. Stein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of genetic variation in the organic cation transporters OCT1, OCT2 and multidrug and toxin extrusion 1 transporter protein genes with the gastrointestinal side effects and lower BMI in metformin-treated type 2 diabetes patients
- (2012) Linda Tarasova et al. Pharmacogenetics and Genomics
- Enhancing the Prioritization of Disease-Causing Genes through Tissue Specific Protein Interaction Networks
- (2012) Oded Magger et al. PLoS Computational Biology
- Clinical Pharmacokinetics of Metformin
- (2011) Garry G. Graham et al. CLINICAL PHARMACOKINETICS
- Mechanisms Underlying Metformin-Induced Secretion of Glucagon-Like Peptide-1 from the Intestinal L Cell
- (2011) Andrew J. Mulherin et al. ENDOCRINOLOGY
- Mild hypoglycaemic attacks induced by sulphonylureas related to CYP2C9, CYP2C19 and CYP2C8 polymorphisms in routine clinical setting
- (2011) Osman Gökalp et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- KCNJ11 gene E23K variant and therapeutic response to sulfonylureas
- (2011) Martin Javorsky et al. European Journal of Internal Medicine
- Genome partitioning of genetic variation for complex traits using common SNPs
- (2011) Jian Yang et al. NATURE GENETICS
- Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease
- (2011) Heribert Schunkert et al. NATURE GENETICS
- Renal glucose reabsorption inhibitors to treat diabetes
- (2011) Clifford J. Bailey TRENDS IN PHARMACOLOGICAL SCIENCES
- The Na+/glucose cotransporters: from genes to therapy
- (2010) R. Sabino-Silva et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Novel biological insights emerging from genetic studies of type 2 diabetes and related metabolic traits
- (2010) N Maneka G De Silva et al. CURRENT OPINION IN LIPIDOLOGY
- Common Variants in 40 Genes Assessed for Diabetes Incidence and Response to Metformin and Lifestyle Intervention in the Diabetes Prevention Program
- (2010) K. A. Jablonski et al. DIABETES
- Variation at the NFATC2 Locus Increases the Risk of Thiazolidinedione-Induced Edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) Study
- (2010) S. D. Bailey et al. DIABETES CARE
- Effect of sulphonylurea treatment on glycaemic control is related to TCF7L2 genotype in patients with type 2 diabetes
- (2010) Z. Schroner et al. DIABETES OBESITY & METABOLISM
- Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: a comparative review
- (2010) C. F. Deacon DIABETES OBESITY & METABOLISM
- Common polymorphisms of the peroxisome proliferator-activated receptor–γ (Pro12Ala) and peroxisome proliferator-activated receptor–γ coactivator–1 (Gly482Ser) and the response to pioglitazone in Chinese patients with type 2 diabetes mellitus
- (2010) Ming-Chia Hsieh et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes
- (2010) Kaixin Zhou et al. NATURE GENETICS
- Common SNPs explain a large proportion of the heritability for human height
- (2010) Jian Yang et al. NATURE GENETICS
- Drug Off-Target Effects Predicted Using Structural Analysis in the Context of a Metabolic Network Model
- (2010) Roger L. Chang et al. PLoS Computational Biology
- Familial Renal Glucosuria and SGLT2: From a Mendelian Trait to a Therapeutic Target
- (2009) R. Santer et al. Clinical Journal of the American Society of Nephrology
- Loss-of-Function CYP2C9 Variants Improve Therapeutic Response to Sulfonylureas in Type 2 Diabetes: A Go-DARTS Study
- (2009) K Zhou et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Reduced-Function SLC22A1 Polymorphisms Encoding Organic Cation Transporter 1 and Glycemic Response to Metformin: A GoDARTS Study
- (2009) K. Zhou et al. DIABETES
- Insulin Storage and Glucose Homeostasis in Mice Null for the Granule Zinc Transporter ZnT8 and Studies of the Type 2 Diabetes-Associated Variants
- (2009) T. J. Nicolson et al. DIABETES
- Genetic influences on the insulin response of the beta cell to different secretagogues
- (2009) A. M. C. Simonis-Bik et al. DIABETOLOGIA
- Tissue specificity and the human protein interaction network
- (2009) Alice Bossi et al. Molecular Systems Biology
- HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
- (2009) Ann K Daly et al. NATURE GENETICS
- Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus
- (2009) M L Becker et al. PHARMACOGENOMICS JOURNAL
- Novel therapeutics for type 2 diabetes: Incretin hormone mimetics (glucagon-like peptide-1 receptor agonists) and dipeptidyl peptidase-4 inhibitors
- (2009) E.J. Verspohl PHARMACOLOGY & THERAPEUTICS
- Ser1369Ala Variant in Sulfonylurea Receptor Gene ABCC8 Is Associated With Antidiabetic Efficacy of Gliclazide in Chinese Type 2 Diabetic Patients
- (2008) Y. Feng et al. DIABETES CARE
- Exploiting Complexity and the Robustness of Network Architecture for Drug Discovery
- (2008) M. K. Hellerstein JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Clinical Risk Factors, DNA Variants, and the Development of Type 2 Diabetes
- (2008) Valeriya Lyssenko et al. NEW ENGLAND JOURNAL OF MEDICINE
- 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
- (2008) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
- HLA-B*5701 Screening for Hypersensitivity to Abacavir
- (2008) Simon Mallal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genome-wide approaches to identify pharmacogenetic contributions to adverse drug reactions
- (2008) M R Nelson et al. PHARMACOGENOMICS JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now